Nuzenio

After Raising Xdemvy

After Raising Xdemvy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:32 GMT Tarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMT Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet - TipRanksTipRanks · Fri, 07 Aug 2026 02:15:46 GMT Tarsus Pharmaceuticals Raises 2026 XDEMVY Net Pdt Sales Guidance to $685M-$705M >TARS - MoomooMoomoo · Thu, 06 Aug 2026 18:00:39 GMT Earnings call transcript: Tarsus beats revenue in Q2 2026, but EPS miss weighs on shares - Investing.comInvesting.com · Thu, 06 Aug 2026 13:00:00 GMT Tarsus’ pending Alkeus deal targets Stargardt disease in 36,000+ U.S. patients - Stock TitanStock Titan · Thu, 06 Aug 2026 11:08:50 GMT

Timeline

Sun, 09 Aug 2026 08:50:32 GMTWhy Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.st

Sat, 08 Aug 2026 01:11:15 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.st

Fri, 07 Aug 2026 02:15:46 GMTTarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet - TipRanks

Thu, 06 Aug 2026 18:00:39 GMTTarsus Pharmaceuticals Raises 2026 XDEMVY Net Pdt Sales Guidance to $685M-$705M >TARS - Moomoo

Thu, 06 Aug 2026 13:00:00 GMTEarnings call transcript: Tarsus beats revenue in Q2 2026, but EPS miss weighs on shares - Investing.com

Thu, 06 Aug 2026 11:08:50 GMTTarsus’ pending Alkeus deal targets Stargardt disease in 36,000+ U.S. patients - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

TARS5 live mentions Tarsus3 live mentions Investing3 live mentions Why Tarsus Pharmaceuticals2 live mentions Is Up2 live mentions Sales Guidance And2 live mentions Acquiring Alkeus2 live mentions Tarsus Pharmaceuticals2 live mentions Stock Can Revenue2 live mentions Momentum Outrun Rising2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for After Raising Xdemvy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.